Famotidine Injection is indicated for the short term treatment of duodenal and gastric ulcers and gastroesophageal reflux disease. Famotidine Injection is therapeutically equivalent to the brand product Pepcid Injection of Merck.
Akorn-Strides is a joint venture that was formed in 2005 by Akorn, and Strides Arcolab. The primary mission for the joint venture is to develop liquid, lyophilized and dry powder formulations of generic injectable products targeting several therapeutic markets with a major focus on anti-infectives, analgesics and CNS medicines.